Edel del
Barco Morillo
Profesor Asociado CC. Salud
Hospital Universitario de Guadalajara
Guadalajara, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario de Guadalajara (2)
2021
-
Lung cancer patients with COVID-19 in Spain: GRAVID study
Lung Cancer, Vol. 157, pp. 109-115
-
Osimertinib in advanced EGFR-T790M mutation-positive non-small cell lung cancer patients treated within the Special Use Medication Program in Spain: OSIREX-Spanish Lung Cancer Group
BMC Cancer, Vol. 21, Núm. 1